Aprio Expands Midwest, Strengthens QSR Outsourcing with Mize CPAs Inc. and Prism Financial Group, L.L.C. Acquisition

ATLANTA, Sept. 19, 2025 /PRNewswire/ — Top 25 powerhouse business advisory and accounting firm, Aprio, continues to redefine professional services and today announced it has entered into agreements to acquire Mize CPAs Inc. (“Mize”), Midwest-based accounting and advisory firm for entrepreneurs and McDonald’s Owner/Operators, along with its affiliated wealth management firm, Prism Financial Group, L.L.C. (“Prism”). […]

Elmo Motion Control Continues the North American 2025 Roadshow, with a Focus on Robotics

PETAH TIKVA, Israel, Sept. 19, 2025 /PRNewswire/ — Elmo Motion Control, a global technology leader in motion control solutions, is pleased to reveal its latest innovations, which will be displayed at four industry events in the Americas: Humanoid Robot Forum in Seattle, Washington on September 23, 2025; RoboBusiness in Santa Clara, California from October 15-16; International Robot […]

FSK Prices Public Offering of $400,000,000 6.125% Unsecured Notes Due 2031

PHILADELPHIA and NEW YORK, Sept. 19, 2025 /PRNewswire/ — FS KKR Capital Corp. (NYSE: FSK) announced that it has priced an underwritten public offering of $400,000,000 in aggregate principal amount of its 6.125% unsecured notes due 2031 (the “Notes”). The Notes will mature on January 15, 2031 and may be redeemed in whole or in […]

Immutable Seizes $121B Opportunity with Launch of Mobile Gaming Division

SYDNEY, Sept. 19, 2025 /PRNewswire/ — Immutable, the global leader in gaming, today announced the launch of its Mobile Gaming Division, a specialist taskforce dedicated to bringing their partner games into the $121 billion mobile market. This announcement comes on the back of one of the strongest years in Immutable’s history: Major CEX and stablecoin […]

Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at ACR 2025

SHANGHAI and HONG KONG, Sept. 19, 2025 /PRNewswire/ — Antengene Corporation Limited (“Antengene“, SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematologic malignancies and solid tumors, today announced that it will release the latest preclinical data of ATG-201 (CD19 x CD3 TCE) in […]

Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at ACR 2025

SHANGHAI and HONG KONG, Sept. 19, 2025 /PRNewswire/ — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) today announced that it will release the latest preclinical data of ATG-201 (CD19 x CD3 TCE) in Poster Presentations at the 2025 American College of Rheumatology (ACR) Annual Meeting, taking place from October 24th to October 29th in Chicago, IL, […]

Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today that it has received U.S. Food and Drug Administration (FDA) approval for the Altaviva™ device. The […]